Showing posts with label In Vitro Diagnostics. Show all posts
Showing posts with label In Vitro Diagnostics. Show all posts

Tuesday 27 August 2013

Global Business Survey: Global Industry Hemostasis Diagnostics Market Growth 2013 - 2019



Hemostasis is the phenomenon of interaction between platelets, blood vessels and coagulation protein which helps to stop the bleeding. In addition, this process also maintains the blood flow in the blood vessels. Bleeding disorders could be a result of vascular and coagulation abnormalities. Hemostasis diagnostics helps in detection of these abnormalities and assists in proper treatment. Hemostasis diagnostic tests include Activated Partial Prothrombin Time (APPT), Prothrombin time (PT), and Fibrinogen assay. 


PT test is performed by extraction of the blood sample and then blood cells are separated from the blood through centrifugation process. The patient’s plasma is then added to these cells to convert prothrombin to thrombin through tissue factors (V, VII and X) present in the plasma. This helps in detection of factors V, VII and X, Fibrinogen and Prothrombin in the blood sample. This test thus assists in the detection of hemostasis disorders. However in APPT, kininogen, prekallikrein are added to the blood cells which converts factor XI to XIa and helps in detection of any the abnormality related to the absence of XIa. In fibrinogen assay, plasma, bovine and imidazole buffered saline solutions are used to quantify fibrinogen content in blood sample.

Hemostasis disorder results in venous thromboembolism, acute coronary syndrome, dessiminated intravascular coagulation and postsurgical bleeding. Various cancers such as breast, kidney, liver, blood and lungs cancer are the major cause of hemostasis disorders. Amongst all these, liver cancer increases the risk of hemostasis disorders since it produces most clotting factors and inhibitors. In addition, it also produces numerous proteins which are involved in the process of fibrinoysis. In 2012, it has been estimated that around 120,000 people were suffering from liver cancer and is expected to grow exponentially. 

This exponential growth of liver cancer would augment the growth of hemostasis diagnostics market. Moreover, rise in aging population worldwide is increasing the accidental rate such as falling and injuries would also support the growth of this market. Hemostasis diagnostic tests are also performed prior to operation to test for quick healing process. This would also boost the growth of hemostasis diagnostic market worldwide.

Some of the market players in homeostasis diagnostic market globally include Abbott Laboratories, Siemens Inc., Beckman Coulter and Danaher Corporation, Instrumentation Laboratory and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World 

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/173421

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamicsIt provides a forward looking perspective on different factors driving or restraining market growth It provides a technological growth map over time to understand the industry growth rateIt provides a seven-year forecast assessed on the basis of how the market is predicted to grow It helps in understanding the key product segments and their futureIt provides pin point analysis of changing competition dynamics and keeps you ahead of competitorsIt helps in making informed business decisions by having complete insights of markeand by making in-depth analysis of market segments It provides distinctive graphics and exemplified SWOT analysis of major market segments


Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948

Monday 26 August 2013

New Study: Global Industry Coxsackievirus Diagnostics Market Growth 2013 - 2019



Coxsackieviruses are non-enveloped viruses belonging to the picornaviridae family and enterovirus genus that possess linear single-stranded RNA as their genetic material. Based on their pathogenecity tested on mice, they are further categorized into group A and group B viruses. Group A viruses are known to cause skin and mucous membrane infections leading to disorders such as herpangina, hand-foot-and-mouth (HFM) disease and acute hemorrhagic conjunctivitis (AHC), whereas, group B viruses infect the pancreas, liver and heart leading to various conditions such as pericarditis, hepatitis, myocarditis and pleurodynia. 


According to the estimations of Centers for Disease Control and Prevention (CDC), out of all the neonatal enterovirus infections from the year 1983 – 2003, coxsackievirus infections accounted for around 25% share. People from all age groups get infected by coxsackievirus but children are more susceptible to infection. Fetuses or newborns are at a high risk of infection if their mother gets infected during pregnancy. These viruses are found in the feces, fluid in blisters, nasal secretions and saliva of infected patients.

Patients infected with coxsackievirus are diagnosed by the appearance of blisters on the hands, mouth and feet. In rare instances, viral identification tests can be performed that involves the use of real time-PCR for amplification of the DNA sample. This type of test distinguishes the virus at the genus, species and subtype level of nomenclature. Tylenol (acetaminophen) is usually administered for symptomatic treatment to reduce fever; other treatment options include Benadryl (diphenhydramine). The coxsackievirus diagnostics market can be segmented on the basis of the type of diagnostic tests performed in various hospitals, private laboratories, etc., instrumentation and geography. 

The major factors driving the growth of this market are increasing incidence of coxsackievirus infections, increased awareness among the public and rigorous government initiatives to reduce the incidences of these infections. Lack of resources and accessibility in remote areas is one of the key factors that may mask the growth of this market. Some of the leading players in this market include Abbott Laboratories, Danaher Corporation, Affymetrix, Inc., Bio-Rad Laboratories, Inc. and Hologic Corporation.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/173401

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments


Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948

Thursday 22 August 2013

Top Rated Report: Global Industry In Vitro Diagnostics Market Size 2012 - 2018: MarketResearchReport



In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 – 2018, keeping 2011 as the base year.


The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report.

The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The global market for in vitro diagnostics is segmented on the basis of geography into North America, Europe, Asia-Pacific and rest of the world (RoW) regions and this market is provided in terms of USD million.

This report includes the market shares of key players in 2011. Moreover, company profiles for some of the key players are included in the report in terms of company overview, financial overview, business strategies, recent developments and product portfolio. The major companies included in the report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.

The global in vitro diagnostics market is categorized into the following segments:

Market by Products

U.S.
  • Clinical Chemistry
  • Immunoassay
  • Diabetes Testing
  • Blood Testing
  • Molecular Diagnostics
  • Others (Flow Cytometry, Microbiological Diagnostic Techniques)

India
  • Clinical Chemistry
  • Immunoassay
  • Diabetes Testing
  • Blood Testing
  • Molecular Diagnostics
  • Others (Flow Cytometry, Microbiological Diagnostic Techniques)

China
  • Clinical Chemistry
  • Immunoassay
  • Diabetes Testing
  • Blood Testing
  • Molecular Diagnostics
  • Others (Flow Cytometry, Microbiological Diagnostic Techniques)

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/172444


Market by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948